105 related articles for article (PubMed ID: 25780002)
1. Primary sclerosing cholangitis: detailed histologic assessment and integration using bioinformatics highlights arterial fibrointimal hyperplasia as a novel feature.
Carrasco-Avino G; Schiano TD; Ward SC; Thung SN; Fiel MI
Am J Clin Pathol; 2015 Apr; 143(4):505-13. PubMed ID: 25780002
[TBL] [Abstract][Full Text] [Related]
2. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].
Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D
Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011
[TBL] [Abstract][Full Text] [Related]
3. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
[TBL] [Abstract][Full Text] [Related]
4. Comparative histologic features among liver biopsies with biliary-pattern injury and confirmed clinical diagnoses.
Yu S; Vidal B; Peric M; Rosenbaum MW; Cates JMM; Gonzalez RS
Hum Pathol; 2024 Apr; 146():8-14. PubMed ID: 38479481
[TBL] [Abstract][Full Text] [Related]
5. Primary sclerosing cholangitis.
Rodriguez HJ; Bass NM
Semin Gastrointest Dis; 2003 Oct; 14(4):189-98. PubMed ID: 14719769
[TBL] [Abstract][Full Text] [Related]
6. Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.
Bernuzzi F; Marabita F; Lleo A; Carbone M; Mirolo M; Marzioni M; Alpini G; Alvaro D; Boberg KM; Locati M; Torzilli G; Rimassa L; Piscaglia F; He XS; Bowlus CL; Yang GX; Gershwin ME; Invernizzi P
Clin Exp Immunol; 2016 Jul; 185(1):61-71. PubMed ID: 26864161
[TBL] [Abstract][Full Text] [Related]
7. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
8. Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR.
Wunsch E; Klak M; Wasik U; Milkiewicz M; Blatkiewicz M; Urasinska E; Barbier O; Bielicki D; Bogdanos DP; Elias E; Milkiewicz P
J Immunol Res; 2015; 2015():571353. PubMed ID: 26504856
[TBL] [Abstract][Full Text] [Related]
9. Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.
Carpino G; Cardinale V; Renzi A; Hov JR; Berloco PB; Rossi M; Karlsen TH; Alvaro D; Gaudio E
J Hepatol; 2015 Nov; 63(5):1220-8. PubMed ID: 26119688
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
11. [Cholestatic liver diseases].
Grimm D; Thimme R
Ther Umsch; 2011 Apr; 68(4):195-9. PubMed ID: 21452140
[TBL] [Abstract][Full Text] [Related]
12. IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis.
Zhang L; Lewis JT; Abraham SC; Smyrk TC; Leung S; Chari ST; Poterucha JJ; Rosen CB; Lohse CM; Katzmann JA; Wu TT
Am J Surg Pathol; 2010 Jan; 34(1):88-94. PubMed ID: 20035148
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
14. [Cholestatic liver diseases].
Thimme R; Opitz OG; Blum HE; Kreisel W
Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
[TBL] [Abstract][Full Text] [Related]
15. Papillary bile duct dysplasia in primary sclerosing cholangitis.
Ludwig J; Wahlstrom HE; Batts KP; Wiesner RH
Gastroenterology; 1992 Jun; 102(6):2134-8. PubMed ID: 1587434
[TBL] [Abstract][Full Text] [Related]
16. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
[TBL] [Abstract][Full Text] [Related]
17. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
18. Primary sclerosing cholangitis: evaluation with MR cholangiography-a case-control study.
Fulcher AS; Turner MA; Franklin KJ; Shiffman ML; Sterling RK; Luketic VA; Sanyal AJ
Radiology; 2000 Apr; 215(1):71-80. PubMed ID: 10751470
[TBL] [Abstract][Full Text] [Related]
19. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
[TBL] [Abstract][Full Text] [Related]
20. Comparative MRI analysis of morphologic patterns of bile duct disease in IgG4-related systemic disease versus primary sclerosing cholangitis.
Tokala A; Khalili K; Menezes R; Hirschfield G; Jhaveri KS
AJR Am J Roentgenol; 2014 Mar; 202(3):536-43. PubMed ID: 24555589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
